8 NUB assessments of high-risk medical devices (§ 137h)
Hospitals can treat patients with novel methods as soon as they become available. The treatment is reimbursed by SHI funds within the
Tag: G-BA
Joint HTAs are finally coming to Germany
It’s been a long time in the making, but now the G-BA finally accepted a compromise on joint HTAs conducted at the
G-BA meetings
Ever wondered if patients influence the G-BA decision-making?
Orphan drug re-assessments
What happens when the sales for an orphan drug exceed €50 mn in a 12 months period?
G-BA publishes an overview of all method assessments
For anyone working on German market access and / or medical devices, these G-BA news might be interesting. The link to the